Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Donald A Bergstrom is President, R&D at Relay Therapeutics. OQRO lists 12 transactions filed with the SEC under this name, the latest on Oct 30, 2026, each linked to the official Form 4.
President, R&D
Disclosures on record
12
Companies involved
1
As of the latest filing on , Donald A Bergstrom reported holding 396,878 shares of Relay Therapeutics (RLAY), worth about $7.18M at the last close of $18 (Nov 13, 2026). In the last 12 months, Donald A Bergstrom sold $42K in 1 sale.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Relay Therapeutics RLAY | 396,878 | 397K direct | $18 | $7.18M | Oct 28, 2026 |
Is this Donald A Bergstrom’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Relay TherapeuticsRLAY
12 disclosures · Oct 2024 – Oct 2026 · 12 sold
Oct 28, 2026Sold~$42Kdisclosed Oct 30
DetailsOfficial recordJul 29, 2025Sold~$98Kdisclosed Jul 30
DetailsOfficial recordJul 28, 2025Sold~$15Kdisclosed Jul 30
DetailsOfficial recordApr 30, 2025Sold~$82Kdisclosed May 1
DetailsOfficial recordApr 28, 2025Sold~$13Kdisclosed May 1
DetailsOfficial recordMar 27, 2025Sold~$2.8Kdisclosed Mar 31
DetailsOfficial recordJan 29, 2025Sold~$211Kdisclosed Jan 31
DetailsOfficial recordJan 30, 2025Sold~$136Kdisclosed Jan 31
DetailsOfficial recordJan 28, 2025Sold~$15Kdisclosed Jan 31
DetailsOfficial recordDec 27, 2024Sold~$2.9Kdisclosed Dec 31
DetailsOfficial recordOct 28, 2024Sold~$16Kdisclosed Oct 30
DetailsOfficial recordSep 27, 2024Sold~$4.9Kdisclosed Oct 1
DetailsOfficial recordDonald A Bergstrom has no open-market purchase on record since 2021. Sales in each of the last 6 years.
Donald A Bergstrom reported 0 open-market purchases and 55 sales since 2021; no open-market purchase.
| Year | Bought | Sold |
|---|---|---|
| 2026 | — | $42K1×1 trade |
| 2025 | — | $574K8×8 trades |
| 2024 | — | $101K7×7 trades |
| 2023 | — | $167K9×9 trades |
| 2022 | — | $4.57M24×24 trades |
| 2021 | — | $4.35M6×6 trades |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
On the latest SEC Form 4, dated Oct 28, 2026, Donald A Bergstrom reported holding 396,878 shares of Relay Therapeutics (RLAY). At the last close of $18 on Nov 13, 2026, that is about $7.18M. This is the stake disclosed in filings, not a net worth.
In SEC filings of the last 12 months, Donald A Bergstrom reported 1 open-market sale worth $42K, and no open-market purchase. Shares withheld for taxes, gifts and option exercises are not counted in these totals.
Donald A Bergstrom has no open-market purchase on record since 2021. Sales in each of the last 6 years.
In SEC filings since 2021: no open-market purchase is on record; the latest open-market sale is from 2026.
Relay Therapeutics (RLAY), from 2021 to 2026: 0 purchases and 55 sales.
Donald A Bergstrom reported 0 open-market purchases and 55 sales here, 2021 to 2026.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
